IRD
Opus Genetics
IRD
IRD
30 hedge funds and large institutions have $8.62M invested in Opus Genetics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
17% less funds holding
Funds holding: 36 → 30 (-6)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
Holders
30
Holding in Top 10
–
Calls
$701K
Puts
$664K
Top Buyers
| 1 | +$4.86M | |
| 2 | +$274K | |
| 3 | +$226K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$223K |
| 5 |
Two Sigma Investments
New York
|
+$190K |
Top Sellers
| 1 | -$1.74M | |
| 2 | -$417K | |
| 3 | -$204K | |
| 4 |
Goldman Sachs
New York
|
-$197K |
| 5 |
Renaissance Technologies
New York
|
-$188K |